CLOONEY'S BROADWAY WINDFALL

Key Takeaways

• Clooney earned roughly $9 million from the limited‑run play
• Star royalty was 10% of weekly grosses above $1.25 million
• Investors saw about a 55% return after recouping $9.5 million
• Production benefited from a $3 million New York state tax credit
• Ticket prices topped $825, yet 2,000 student tickets were subsidized

Summary

George Clooney’s Broadway debut in Good Night, and Good Luck generated $48 million in gross sales and earned him roughly $9 million, combining a $125,000 weekly salary, 10% star royalties, and profit participation. The limited‑run play broke weekly box‑office records at the Winter Garden Theatre, culminating in a $4.3 million final‑week gross. Clooney also collected author royalties, producer shares, and adjusted net profits, while the production secured a $3 million New York state tax credit. Investors recouped their $9.5 million capitalization and realized about a 55% return.

Pulse Analysis

Broadway’s financial landscape has long been dominated by long‑running spectacles, but George Clooney’s foray with Good Night, and Good Luck illustrates a shift toward high‑impact limited engagements. By pairing a modest base salary with a generous upside—10% of weekly grosses above a $1.25 million threshold—the production leveraged Clooney’s star power to drive ticket demand, pushing weekly grosses to an average of $3.4 million and a record‑setting $4.3 million final week. This hybrid compensation model mirrors Hollywood’s profit‑participation deals, offering a blueprint for future productions seeking to balance risk and reward.

The financial breakdown reveals a multi‑layered revenue stream: Clooney’s $125,000 weekly salary, $3.5 million in star royalties, $1.25 million in profit participation, plus $3 million in author royalties shared with Grant Heslov. Producers collectively earned over $7 million, while director David Cromer secured $1.7 million in royalties, underscoring how top‑tier talent can command substantial upside beyond traditional salaries. The $3 million state tax credit further boosted net returns, enabling investors to achieve a 55% profit after recouping the $9.5 million capitalization—a rare feat for a limited‑run play.

Clooney’s success signals broader implications for the theater industry. As investors recognize the profitability of star‑driven, short‑run productions, we may see more high‑profile actors crossing into Broadway, negotiating royalty structures that align their interests with box‑office performance. Simultaneously, the looming closure of the New York tax‑credit loophole could pressure producers to demonstrate fiscal discipline without government subsidies. Ultimately, the case study reinforces that strategic talent contracts, combined with savvy financial incentives, can transform Broadway from a cost‑center into a lucrative, scalable enterprise.